Proactive Investors - Run By Investors For Investors

Heritage Cannabis sign deal to work with Canntab Therapeutics

Heritage Cannabis (CSE:CANN) President and CEO Clint Sharples and Canntab Therapeutics (CSE:PILL) CFO Richard Goldstein joined Christine Corrado from Proactive Investors New York to talk about their partnership that seems to really benefit both companies.

Heritage’s subsidiary Purefarma Solutions will provide
processing services for hemp supplied by Canntab, to their specification, as required for the production of Canntab’s planned ingestible oral cannabis products.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here  
View full CANN profile View Profile

Heritage Cannabis Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use